391 related articles for article (PubMed ID: 28903345)
41. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
42. Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort.
Shboul M; Bani Domi A; Abu Zahra A; Khasawneh AG; Darweesh R
Noncoding RNA Res; 2024 Jun; 9(2):350-358. PubMed ID: 38511065
[TBL] [Abstract][Full Text] [Related]
43. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
[TBL] [Abstract][Full Text] [Related]
45. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
[TBL] [Abstract][Full Text] [Related]
46. Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.
Kong R; Gao J; Si Y; Zhao D
Am J Transl Res; 2017; 9(6):2852-2864. PubMed ID: 28670374
[TBL] [Abstract][Full Text] [Related]
47. Identification of a blood-borne miRNA signature of synovial sarcoma.
Fricke A; Ullrich PV; Heinz J; Pfeifer D; Scholber J; Herget GW; Hauschild O; Bronsert P; Stark GB; Bannasch H; Eisenhardt SU; Braig D
Mol Cancer; 2015 Aug; 14():151. PubMed ID: 26250552
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
49. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.
Galluzzo A; Gallo S; Pardini B; Birolo G; Fariselli P; Boretto P; Vitacolonna A; Peraldo-Neia C; Spilinga M; Volpe A; Celentani D; Pidello S; Bonzano A; Matullo G; Giustetto C; Bergerone S; Crepaldi T
ESC Heart Fail; 2021 Aug; 8(4):2907-2919. PubMed ID: 33934544
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
51. miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers.
Worst TS; Previti C; Nitschke K; Diessl N; Gross JC; Hoffmann L; Frey L; Thomas V; Kahlert C; Bieback K; Crigna AT; Fricke F; Porubsky S; Westhoff N; Hardenberg JV; Nuhn P; Erben P; Michel MS; Boutros M
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877768
[TBL] [Abstract][Full Text] [Related]
52. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
53. Circulating miRNA in Patients Undergoing Total Pancreatectomy and Islet Autotransplantation.
Vasu S; Yang JM; Hodges J; Abu-El-Haija MA; Adams DB; Balamurugan AN; Beilman GJ; Chinnakotla S; Conwell DL; Freeman ML; Gardner TB; Hatipoglu B; Kirchner V; Lara LF; Morgan KA; Nathan JD; Posselt A; Pruett TL; Schwarzenberg SJ; Singh VK; Wijkstrom M; Witkowski P; Naziruddin B; Bellin MD
Cell Transplant; 2021; 30():963689721999330. PubMed ID: 33902338
[TBL] [Abstract][Full Text] [Related]
54. Gingival Tissue MiRNA Expression Profiling and an Analysis of Periodontitis-Specific Circulating MiRNAs.
Buragaite-Staponkiene B; Rovas A; Puriene A; Snipaitiene K; Punceviciene E; Rimkevicius A; Butrimiene I; Jarmalaite S
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569358
[TBL] [Abstract][Full Text] [Related]
55. Plasmatic MicroRNA Signatures in Elderly People with Stable and Unstable Angina.
Cui Y; Song J; Li S; Lee C; Zhang F; Chen H
Int Heart J; 2018 Jan; 59(1):43-50. PubMed ID: 29332918
[TBL] [Abstract][Full Text] [Related]
56. Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.
Khodadadi-Jamayran A; Akgol-Oksuz B; Afanasyeva Y; Heguy A; Thompson M; Ray K; Giro-Perafita A; Sánchez I; Wu X; Tripathy D; Zeleniuch-Jacquotte A; Tsirigos A; Esteva FJ
Oncotarget; 2018 Feb; 9(16):12868-12878. PubMed ID: 29560116
[TBL] [Abstract][Full Text] [Related]
57. Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy.
Mencias M; Levene M; Blighe K; Bax BE; On Behalf Of The Project Group
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916195
[TBL] [Abstract][Full Text] [Related]
58. Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p.
Sebastiani G; Guarino E; Grieco GE; Formichi C; Delli Poggi C; Ceccarelli E; Dotta F
Front Endocrinol (Lausanne); 2017; 8():345. PubMed ID: 29312141
[TBL] [Abstract][Full Text] [Related]
59. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
Samandari N; Mirza AH; Nielsen LB; Kaur S; Hougaard P; Fredheim S; Mortensen HB; Pociot F
Diabetologia; 2017 Feb; 60(2):354-363. PubMed ID: 27866223
[TBL] [Abstract][Full Text] [Related]
60. Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study.
Incoronato M; Grimaldi AM; Mirabelli P; Cavaliere C; Parente CA; Franzese M; Staibano S; Ilardi G; Russo D; Soricelli A; Catalano OA; Salvatore M
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
